|

Sodium Fluoride F-18 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 18 F-NaF, F-18 NaF, Fluorine F 18 Sodium Fluoride, NaF F18, Sodium Fluoride F18

Pipeline

Early 1: 1Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Emory University1

Indications

  • Cancer2
  • Sporadic Papillary Renal Cell Carcinoma1
  • Hereditary Leiomyomatosis and Renal Cell Carcinoma1
  • Papillary Renal Cell Carcinoma1
  • Stage IV Renal Cell Cancer AJCC v81

La Jolla, California1 trial

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

UC San Diego Moores Cancer Center

Phase 2

Atlanta, Georgia1 trial

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Emory University Hospital Midtown

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.